Phenylketonuria Market Upcoming Opportunities, Business Strategies, Current Insights, Regional Developments, Demand and Forecast to 2023-2030
Phenylketonuria (PKU) Market
Overview:
The
Phenylketonuria (PKU) market has witnessed significant growth in
recent years, driven by a combination of factors. PKU, a rare genetic disorder,
has garnered increased attention due to heightened awareness and improved
diagnostic capabilities. This market encompasses various segments, including
pharmaceuticals, medical foods, and diagnostic tools, all contributing to its
expansion. Phenylketonuria (PKU) market was USD 820.57 Million in 2022. It is
projected to reach USD 1,230.05 Million by 2030, indicating a CAGR of 5.2%
during the forecast period.
Phenylketonuria,
often referred to as PKU, is a rare genetic disorder that affects approximately
1 in 10,000 to 15,000 newborns globally. This condition results from a
deficiency of the enzyme phenylalanine hydroxylase, which is responsible for
metabolizing the amino acid phenylalanine (Phe). Without proper enzyme
activity, Phe accumulates in the body, leading to a range of health issues,
particularly affecting the brain.
Sample Request Here: https://www.consegicbusinessintelligence.com/request-sample/1228
Key Players in the Phenylketonuria
(PKU) Market:
·
Cambrooke Therapeutics
·
American Gene Technologies International, Inc.
·
BioMarin Pharmaceutical, Inc.
·
PTC Therapeutics
·
Relief Therapeutics Holding SA
·
Codexis, Inc.
·
Agios Pharmaceuticals Inc
Market Segmentation:
By Type
·
Hyperphenylalaninemia
·
Mild PKU
·
Moderate and Variant
·
Classic PKU
By Product Type
·
Drugs (Kuvan, Pegavaliase, and Others)
·
Nutritional Supplements
·
Others
By Distribution Channel
·
Hospital Pharmacies
·
Retail Pharmacies
·
Online Pharmacies
·
Others
Click Here To Get More Information
About: Phenylketonuria (PKU) Market Report
Regional Analysis:
The
PKU market exhibits regional variations in terms of prevalence, awareness, and
access to treatments. In regions with a higher incidence of PKU, such as parts
of Europe and North America, the market is more established and competitive.
Conversely, regions with lower awareness and limited access to medical
resources present untapped potential for market expansion. Regional analysis
helps identify geographic disparities and informs market strategies to address
these variations effectively.
Contact us:
Consegic Business
intelligence Pvt Ltd.
Contact no: (US) (505) 715-4344
Email: sales@consegicbusinessintelligence.com
Comments
Post a Comment